Gilead Sciences
A listing of content for this category:
| Title | Text |
Updated |
|---|---|---|
| FDA delays decision on first drug to prevent HIV | Federal health regulators have delayed a decision on whether to approve the first pill shown to... | 12 June 2012 |
| HIV pill for prevention debated as FDA ruling nears | An advocacy group concerned about the costs and possible health problems related to a drug being... | 8 March 2012 |
| US drugmaker's HIV prevention pill draws concern | Foster City drugmaker Gilead recently updated its application with the federal Food and Drug... | 2 February 2012 |
| AIDS conference begins in Rome | The head of the United Nations AIDS program called Sunday for an increase in access to drugs that... | 11 January 2012 |
| Gilead's US pricing on HIV meds draws fire | Gilead Sciences chief John Martin figures his HIV drugs won't earn much in under-developed... | 30 June 2011 |
| AIDS prevention pill study halted | Family Health International, a nonprofit involved in AIDS research, announced the new results on... | 18 April 2011 |
